6th Edition of Global Conference on
Addiction Medicine, Behavioral Health and Psychiatry
October 20-22, 2025 | Orlando, Florida, USA
Virtual Reality (VR) and Digital Therapeutics in Mental Health
Immersive technology is redefining how therapy is delivered. Virtual reality (VR) and digital therapeutics in mental health have expanded the toolkit for treating conditions such as PTSD, phobias, and social anxiety through controlled, safe exposure environments. VR simulations allow patients to confront fears or stressors in a structured therapeutic context, while digital therapeutics platforms offer app-based interventions grounded in CBT or mindfulness. These tools are proving especially valuable in remote care and youth mental health settings, where engagement and accessibility can be challenges. The integration of biometric feedback into virtual environments adds a new dimension to real-time emotional monitoring and response. As clinical validation continues, VR is emerging as more than a novelty—it’s a transformative medium for mental healthcare delivery.
Nile Stanley
University of North Florida, United States
Ann Marie Leonard Zabel
Curry College, United States
Denis Larrivee
University of Navarra, Spain
Scharbach Hugues
Paris University, France
Alphonsus Obayuwana
Triple-H Project LLC, United States
Malasri Chaudhery Malgeri
Recovery com, United States
Jana Furstova
Palacký University Olomouc, Czech RepublicSubmit your abstract Today
Title : Tailoring biblio-poetry therapies using AI and biofeedback for addiction treatment
Nile Stanley, University of North Florida, United States
Title : The A-B-C of happiness coaching
Alphonsus Obayuwana, Triple-H Project LLC, United States
Title : Clinical pharmacology of marijuana: Update 2024
Frederick J Goldstein, Philadelphia College of Osteopathic Medicine, United States
Title : Trait-based recovery: Evidence-based trait activation to reduce depression, anxiety, and improve client engagement in addiction treatment
Jason Glenn Roop, The Center for Trait-Based Transformation, United States
Title : An investigation of the factors responsible for ubstance abuse from a cognitive perspective based on a mixed method approach
Adewole Olukorede, Literary Edifice, Italy
Title : A Long-Acting Naltrexone Implant (for Opioid Use Disorder: First-in-Human Phase I Trial)
Steven M Cohen, Akyso Therapeutics, United States